Daniel Link

14PUBLICATIONS
77CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Computational imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 29, 2026
Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AML.

Jeremy T Baeten, Sumedha Agashe, Imene Tabet

|Jul 29, 2025
A clinical guide to TP53 mutations in myeloid neoplasms.

Samuel Urrutia, Terrence N Wong, Daniel C Link

|Jul 15, 2025
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy.

Jie Liu, Duc Tran, Liying Xue

|Jul 02, 2025
How chemotherapy shapes hematopoietic stem cells.

Terrence N Wong, Daniel C Link

|Mar 06, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.

Duc Tran, J Scott Beeler, Jie Liu

|Oct 14, 2023
Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia.

Kimberly B Johansson, Megan S Zimmerman, Iryna V Dmytrenko

Pageof 3

Frequent Collaborators

3 joint publications

Jie Liu

3 joint publications

David H Spencer

3 joint publications

Karolyn A Oetjen

3 joint publications

Timothy J Ley